ATH 12.5% 0.4¢ alterity therapeutics limited

SRPT Duchenne Drug trial hits 5 year mark, page-48

  1. 516 Posts.
    lightbulb Created with Sketch. 13
    Possibly you never got the true information. PCH is a good example. They told you it is caused by dog issues half a year after the first release. One year later, they told you it is very complicated. They never told you whether they had done the animal tests requested by FDA. They never said why they don't follow FDA's first option to provide satisfiable animal results. They never explained openly why their so called strong safety data cannot satisfy FDA. What you were informed are just pieces.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(12.5%)
Mkt cap ! $18.62M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $7.902K 2.037M

Buyers (Bids)

No. Vol. Price($)
40 53603756 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126995306 20
View Market Depth
Last trade - 14.03pm 15/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.